The IN VIVO Blog (blog) | Under One Roof: Roche Talks Up In-House Advantages In Cancer The IN VIVO Blog (blog) That's what Roche is looking to do in hematology, moving from the rituximab base to new drugs like GA101. "We have a number of scenarios that can help us both extend the franchise and potentially replace and extend the franchise," Roche Pharma COO ... |
